TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T46508	Voltage-gated potassium channel	B2MX7W	6-Methoxytryptamine	Investigative	17654	C11H14N2O	190.24	COC1=CC2=C(C=C1)C(=CN2)CCN	IC50 = 1910000000000 nM	Non binder
T46508	Voltage-gated potassium channel	B8RSM7	[(4-Methylphenyl)sulfonyl](2-{2-[2-(2-{[(4-methylphenyl)sulfonyl]amino}ethoxy) ethoxy]ethoxy}ethyl)amine	Investigative	4213527	C22H32N2O7S2	500.6	CC1=CC=C(C=C1)S(=O)(=O)NCCOCCOCCOCCNS(=O)(=O)C2=CC=C(C=C2)C	IC50 = 479000000000000 nM	Non binder
T46508	Voltage-gated potassium channel	B8SB6M	Piperazine, 1-[2-[(4-chlorophenyl)sulfonyl]ethyl]-4-(phenylmethyl)-	Investigative	2823155	C19H23ClN2O2S	378.9	C1CN(CCN1CCS(=O)(=O)C2=CC=C(C=C2)Cl)CC3=CC=CC=C3	IC50 = 16600000000000 nM	Non binder
T46508	Voltage-gated potassium channel	BF8IJ0	N1-(5-Chloro-6-methyl-2-pyridin-3-YL-pyrimidin-4-YL)-ethane-1,2-diamine	Investigative	2725955	C12H14ClN5	263.72	CC1=C(C(=NC(=N1)C2=CN=CC=C2)NCCN)Cl	IC50 = 12000000000000 nM	Non binder
T46508	Voltage-gated potassium channel	BK7XH9	N-(2-Aminoethyl)-5-chloronaphthalene-1-sulfonamide	Investigative	1960	C12H13ClN2O2S	284.76	C1=CC2=C(C=CC=C2Cl)C(=C1)S(=O)(=O)NCCN	IC50 = 55000000000000 nM	Non binder
T46508	Voltage-gated potassium channel	BPT59A	1-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-phenoxyethanamine;hydrochloride	Investigative	44418816	C16H18ClNO3	307.77	C1COC2=C(O1)C=CC(=C2)C(COC3=CC=CC=C3)N.Cl	IC50 = 14800000000000 nM	Non binder